Ellevest, Inc. Iovance Biotherapeutics, Inc. Transaction History

Ellevest, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 18, 2022	BUY	$6.38 - $18.33 $408 - $1,173	64 Added 177.78%	100 $1,000
Q1 2022 Apr 19, 2022	SELL	$12.38 - $19.1 $185 - $286	-15 Reduced 29.41%	36 $1,000
Q4 2021 Jan 24, 2022	SELL	$16.55 - $27.63 $1,439 - $2,403	-87 Reduced 63.04%	51 $1,000
Q3 2021 Oct 19, 2021	BUY	$20.35 - $26.63 $895 - $1,171	44 Added 46.81%	138 $3,000
Q2 2021 Jul 13, 2021	BUY	$16.33 - $33.07 $636 - $1,289	39 Added 70.91%	94 $2,000
Q4 2020 Feb 04, 2021	BUY	$28.04 - $50.26 $280 - $502	10 Added 22.22%	55 $3,000
Q3 2020 Oct 26, 2020	BUY	$27.75 - $36.3 $499 - $653	18 Added 66.67%	45 $1,000
Q2 2020 Jul 06, 2020	BUY	$27.21 - $41.0 $734 - $1,107	27 New	27 $1,000
Q1 2020 Apr 13, 2020	SELL	$19.54 - $38.85 $683 - $1,359	-35 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$17.95 - $29.41 $628 - $1,029	35 New	35 $1,000

314

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.28B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.